Viewing Study NCT01462604


Ignite Creation Date: 2025-12-24 @ 9:22 PM
Ignite Modification Date: 2026-05-27 @ 4:14 PM
Study NCT ID: NCT01462604
Status: COMPLETED
Last Update Posted: 2018-06-19
First Post: 2011-09-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Patient's Adherence to TYKERB™/TYVERB™ + Capecitabine in Metastatic Breast Cancer
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module